Par Drugs And Chemicals Limited has informed the Exchange regarding 'Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited has submitted a disclosure to the exchange under Regulation 36(1)(b) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. This regulation requires companies to send an abridged version of the annual report along with the notice of the annual general meeting to their shareholders. The specific contents of the abridged report or details about the AGM are not included in this filing. Shareholders should expect to receive the AGM notice and abridged annual report from the company shortly.
This is a routine regulatory compliance filing with no direct impact on stock price or shareholder value. It simply signals that the company is following the standard process of convening its annual general meeting and sharing the abridged annual report with shareholders as required by SEBI rules.